Biomea Fusion, Inc. (BMEA)

1.27 -0.03 (-2.31%) USD  |  NASDAQ  |  Oct 02, 16:00
1.29 +0.02 (+1.57%) Pre-Market: 08:03
More

Biomea Fusion Research and Development Expense (% of Annual Revenues)

Research and Development Expense (% of Annual Revenues) Chart

View Research and Development Expense (% of Annual Revenues) for BMEA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Research and Development Expense (% of Annual Revenues) Data

View and export this data back to . Start Trial.
Date Value

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (% of Annual Revenues) Range, Past 5 Years

View Research and Development Expense (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (% of Annual Revenues) Benchmarks

View Research and Development Expense (% of Annual Revenues) Benchmarks
Start Trial
REGENXBIO, Inc. Upgrade
Compass Therapeutics, Inc. --
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Savara, Inc. --